D.E. Shaw & Co
KBIO

D.E. Shaw & Co’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

D.E. Shaw & Co’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,466
Closed -$20K – 4387
2014
Q4 		$20K Sell
1,466
-156
-10% -$2.23K ﹤0.01% 3955
2014
Q3 		$20K Sell
1,622
-25
-2% -$345 ﹤0.01% 4044
2014
Q2 		$30K Buy
+1,647
New +$28.2K ﹤0.01% 4125

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co's KBIO Position: Q1 2015 in Review

D.E. Shaw & Co sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2015, closing a stake of 1,466 shares — an estimated $20K sold.

D.E. Shaw & Co first reported a position in KBIO in Q2 2014 and held it in 3 quarters. The position peaked at $30K in Q2 2014. 24 funds tracked by Wall St. Rank hold KBIO as of Q1 2015.

  • D.E. Shaw & Co reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,466 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2015, an estimated $20K.
  • D.E. Shaw & Co first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2014 and held it in 3 quarters.
  • D.E. Shaw & Co's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $30K in Q2 2014.
  • 24 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2015.

Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.